AaronGMammoserMDMS

PubMed

• 39 citations
  Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma
  Stefania Maraka, Morris D. Groves, Aaron Mammoser, Isaac Melguizo-Gavilanes, Charles A. Conrad
  Cancer. 2019-02-01
• 212 citations
  A Bacterial Artificial Chromosome Library for Sequencing the Complete Human Genome
  Kazutoyo Osoegawa, Aaron G. Mammoser, Chenyan Wu, Eirik Frengen, Changjiang Zeng
  Genome Research. 2001-03-01
• 62 citations
  cDNA sequence and in vitro folding of GsMTx4, a specific peptide inhibitor of mechanosensitive channels
  Kimberly Laskie Ostrow, Aaron Mammoser, Thomas M. Suchyna, Frederick Sachs, Robert E. Oswald
  Toxicon. 2003-09-01

Journal Articles

• Hypercellularity Components of Glioblastoma Identified by High b-value Diffusion-Weighted Imaging  
  Pramanik PP, Parmar HA, Mammoser AG, Junck L, Kim MM, Tsien CI, Lawrence TS, Cao YC, Int J Radiat Oncol Biol Phys, 1/1/2015
• Gemcitabine Plus Radiation Therapy for High Grade Glioma: Long-term Results of a Phase I Dose-Escalation Study  
  Kim M, Camelo-Piragua S, Schipper M, Tao Y, Normolle D, Junck L, Mammoser A, Betz B, Cao Y, Kim C, Heth J, Sagher O, Lawrence T, Tsien C, International Journal of Radiation Oncology*Biology*Physics, 1/1/2015
• Novel clinical trials in neuro-oncology  
  Mammoser AG, Blas-Boria DE, Gilbert MR, Clin Investig, 1/1/2011

Books/Book Chapters

• Neurobiology of Disease 
  Chapter: "Infiltrative Astrocytomas: WHO grade II-Diffuse Astrocytomas; WHO grade III-Anaplastic Astrocytoma." 
  Mammoser AGEditors: Johnston MV, Adams HP, Fatemi A.Oxford University Press, New York, NYEdition 2nd,2016
• Neurobiology of Disease 
  Chapter: "Glioblastomas." 
  Mammoser AGEditors: Johnston MV, Adams HP, Fatemi A.Oxford University Press, New York, NYEdition 2nd,2016
• Neurologic Complications of Cancer Therapy 
  Chapter: "Neurologic Complications Associated with Biologic Agents." 
  Mammoser AG, Groves MDEditors: Wen PY, Schiff D, and Quant EC.Demos Medical Publishing, New York, NY2012
• Encyclopedia of Sports Medicine 
  Chapter: "Malignant Brain Edema Syndrome." 
  Mammoser AG, Kutcher JSSAGE Publications Inc., Los Angeles, CA2011
• Join now to see all

Abstracts/Posters

• Phase I Lead-in to a Phase II Factorial Study of Temozolomide plus Memantine, Mefloquine, and Metformin as Post-Radiation Adjuvant Therapy for Newly Diagnosed Glioblas...
  Marakas S, Groves MD, Mammoser A, Melguizo-Gavilanes I, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, De Groot JF,..., Journal of Clinical Oncology, 2018 ASCO Annual Meeting, Chicago, IL, 1/20/2018
• Primary CNS lymphoma; a review of the University of Michigan experience 2004-2013.
  Mammoser AG, Weathers S-PS, Seewald NJ, Taylor JMG, Junck L, Journal of Clinical Oncology, 2015 ASCO Annual Meeting, Chicago, IL, 1/1/2015
• A Phase I Dose-Escalation Study of Gemcitabine Plus Standard Radiation Therapy for Malignant High Grade Gliomas.
  Kim M, Schipper M, Cao Y, Junck L, Mammoser AG, Heth J, Sagher O, Lawrence T, Tsien C, Neuro-Oncology, Society for Neuro-Oncology 19th Annual Scientific Meeting, Miami, FL, 1/1/2014
• Phase I Lead-in to a 2x2x2 Factorial Trial of Dose Dense Temozolomide, Memantine,Mefloquine, and Metformin As Post-Radiation Adjuvant Therapy of Glioblastoma (GBM).
  Penas-Prado M, Groves MD, Mammoser AG, Melguizo-Gavilanes I, De Groot JF, Conrad CA, Tremont I, Loghin ME, Puduvalli VK, Sulman EP, Hess K, Aldape KD, Gilbert MR, Yung..., American Society of Clinical Oncology, Chicago, IL, 1/1/2013
• Alternative dosing may improve clinical outcome in bevacizumab-resistant glioblastoma.
  Mammoser AG, Shonka NA, deGroot JF, Neuro-Oncol, 1/1/2011
• Increased risk of cerebral atrophy with prolonged bevacizumab administration.
  Mammoser AG, Shah K, Conrad CA, Neuro-Oncol, 1/1/2011
• Modulating bevacizumab resistance: An alternative dosing strategy at progression.
  Mammoser AG, Shonka Na, deGroot JF, Journal of Clinical Oncology, 1/1/2011
• Join now to see all

Lectures

• "A Tour of Adult Primary Brain Tumors" 
  1/1/2018
• "A Whirlwind Tour of Adult Primary Brain Tumors" 
  1/1/2017
• "WHO Classification of Tumors of the Central Nervous System; A Practical Discussion of the 2016 Revisions to the 4th Edition" 
  1/1/2016
• "The Curious Case of Carol E" 
  1/1/2016
• "Immunotherapeutic Approaches in Glioma Treatment" 
  1/1/2016
• "Current Strategies for Glioma Management: Chemotherapeutics and Targeted Therapies" 
  University of Michigan - 1/1/2015
• Management of Common Spine and Brain Diseases: A Refresher for Primary Care Physicians 
  Troy, MI - 1/1/2015
• "A Lunchtime Tour of Glioma" 
  1/1/2015
• "Introduction to Neuro-Oncology" 
  1/1/2015
• "Neuro-Oncology" 
  1/1/2015
• "CNS Malignancies" 
  1/1/2015
• "Targeting Glioma: Overcoming Challenges and Moving Forward" 
  1/1/2015
• "Admitting Uncertainty; Managing Poor Prognosis Patients" 
  1/1/2015
• "The World of Primary Brain Tumors" 
  1/1/2014
• "Management of Primary Brain Tumors" 
  1/1/2013
• "Primary Brain Tumors: Tumors and Their Treatment" 
  University of Michigan - 1/1/2013
• "Neuro Oncologic Management in Gliomas; 60 Gy +/-Temozolomide Followed by Adjuvant Temozolomide (or not) ... How much is there really to talk about?" 
  1/1/2013
• "Neurologic Complications of Cancer" 
  1/1/2013
• "Primary Brain Tumors" 
  1/1/2012
• "Gliobastoma in 2012; What's New?" 
  1/1/2012
• "Reversible Paraneoplastic Encephalopathy/Cerebellar Syndrome in the Setting of a Low Grade GI Follicular Lymphoma" 
  1/1/2012
• Join now to see all